Intravenous Treprostinil in Severe Inoperable Chronic Thromboembolic Pulmonary Hypertension Using Implantable Pumps—Single-Center Experience over More Than a Decade

Intravenous Treprostinil in Severe Inoperable Chronic Thromboembolic Pulmonary Hypertension Using Implantable Pumps—Single-Center Experience over More Than a Decade

The management of chronic thromboembolic pulmonary hypertension has significantly changed over the last decade with the availability of both specific therapies and interventional treatments. In parallel, implantable pumps for intravenous administration of treprostinil have broadened the spectrum of...

Полное описание

Библиографические подробности
Главные авторы:	Regina Steringer-Mascherbauer, Charlotte Huber, Uwe Fröschl, Dagmar Engleder, Reinhold Függer, Maria Lummersdorfer, Ralf Lenhard, Martin Martinek
Формат:	Статья
Язык:	English
Опубликовано:	MDPI AG 2023-07-01
Серии:	Journal of Cardiovascular Development and Disease
Предметы:	chronic thromboembolic pulmonary hypertension implantable pump intravenous treprostinil
Online-ссылка:	https://www.mdpi.com/2308-3425/10/8/318

Схожие документы

The risk profile change in patients with severe chronic thromboembolic pulmonary hypertension treated with subcutaneous treprostinil
по: Pavel Jansa, и др.
Опубликовано: (2023-07-01)

Long-term experience with implantable infusion pumps for intravenous treprostinil in pulmonary arterial hypertension—procedural safety and system-related complications
по: Regina Steringer-Mascherbauer, и др.
Опубликовано: (2020-11-01)

Combination therapy with riociquat and inhaled treprostinil in inoperable and progressive chronic thromboembolic pulmonary hypertension
по: John W. Swisher, PhD, MD, и др.
Опубликовано: (2017-01-01)

Periprocedural safety and outcome after pump implantation for intravenous treprostinil administration in patients with pulmonary arterial hypertension
по: Jan C. Kamp, и др.
Опубликовано: (2021-05-01)

An implantable pump Lenus pro® in the treatment of pulmonary arterial hypertension with intravenous treprostinil
по: Marcin Kurzyna, и др.
Опубликовано: (2017-12-01)

Venoarterial extracorporeal membrane oxygenation for vasoplegic shock after treprostinil refill of an implanted intravenous pump: a case report
по: Lucía Valencia, и др.
Опубликовано: (2024-01-01)

The effects of standardized intravenous treprostinil in pulmonary arterial hypertension patients after total cavo-pulmonary connection procedure
по: Xiaofeng Wang, и др.
Опубликовано: (2024-10-01)

Failure to tolerate continuous subcutaneous treprostinil in pediatric pulmonary hypertension patients
по: Julia McSweeney, и др.
Опубликовано: (2023-04-01)

Efficacy of oral treprostinil for treating pulmonary arterial hypertension: a systematic review and meta-analysis
по: Lianghua Xiao, и др.
Опубликовано: (2024-09-01)

Design, Development, and Evaluation of Treprostinil Embedded Adhesive Transdermal Patch
по: Ibrahim Alissa, и др.
Опубликовано: (2023-04-01)

Prenatal treprostinil reduces the pulmonary hypertension phenotype in the rat model of congenital diaphragmatic hernia
по: Felix Rafael De Bie, и др.
Опубликовано: (2022-07-01)

The Importance of Dose Escalation in the Treatment of Pulmonary Arterial Hypertension with Treprostinil
по: Piotr Kędzierski, и др.
Опубликовано: (2025-01-01)

Comparison of treprostinil and oral sildenafil for the treatment of persistent pulmonary hypertension of the newborn: a retrospective cohort study
по: Enhuan Wei, и др.
Опубликовано: (2023-11-01)

Peak steps to measure ‘‘capacity for activity’’: Actigraphy in the ADAPT registry with oral treprostinil
по: Daniel Lachant, DO, и др.
Опубликовано: (2025-05-01)

INSPIRE: Safety and tolerability of inhaled Yutrepia (treprostinil) in pulmonary arterial hypertension (PAH)
по: Nicholas S. Hill, и др.
Опубликовано: (2022-07-01)

Pulmonary Hypertension-Associated Right Ventricular Cardiomyocyte Remodelling Reduces Treprostinil Function
по: Aleksandra Judina, и др.
Опубликовано: (2023-12-01)

Evaluation of patients with severe pulmonary hypertension and a range of comorbidities prescribed inhaled treprostinil
по: Aparna C. Swaminathan, и др.
Опубликовано: (2024-11-01)

BREEZE: Open‐label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™ in patients with pulmonary arterial hypertension
по: Leslie A. Spikes, и др.
Опубликовано: (2022-04-01)

Evaluation and Selection of the Inhaler Device for Treprostinil Palmitil Inhalation Powder
по: Helena Gauani, и др.
Опубликовано: (2022-04-01)

Cannabidiol (CBD) for the treatment of subcutaneous treprostinil (Remodulin®) site pain: a case report
по: Jacqueline Brewer, и др.
Опубликовано: (2023-06-01)

Real‐world use of inhaled treprostinil for lung disease‐pulmonary hypertension: A protocol for patient evaluation and prescribing
по: Shelsey W. Johnson, и др.
Опубликовано: (2022-07-01)

Unexpected Acceleration in Treprostinil Delivery Administered by a Lenus Pro® Implantable Pump in Two Patients Treated for Pulmonary Arterial Hypertension
по: Garance Kopp, и др.
Опубликовано: (2020-10-01)

Effect of Inhalation Profile on Delivery of Treprostinil Palmitil Inhalation Powder
по: Helena Gauani, и др.
Опубликовано: (2023-03-01)

Severe bronchospasm and acute respiratory failure associated with inhaled prostacyclin therapy
по: Donna Steinbacher, и др.
Опубликовано: (2024-04-01)

Renal infarction associated with low dose intravenous immunoglobulin in a kidney transplant recipient with sepsis: a case report and literature review
по: Eun Woo Choi, и др.
Опубликовано: (2021-10-01)

Treatment Strategy Options in Inoperable Chronic Thromboembolic Pulmonary Hypertension Patients
по: N. V. Marukyan, и др.
Опубликовано: (2021-05-01)

Balloon pulmonary angioplasty for patients with inoperable chronic thromboembolic pulmonary hypertension
по: N M Danilov, и др.
Опубликовано: (2019-04-01)

Oral Prostacyclin Pathway Agents Used in PAH: A Targeted Literature Review
по: Burger CD, и др.
Опубликовано: (2024-05-01)

Direct prostacyclin transition in pediatric patients with pulmonary hypertension
по: Kelly Merrill, и др.
Опубликовано: (2024-04-01)

Bilateral versus unilateral balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension
по: Cheng Hong, и др.
Опубликовано: (2022-05-01)

Efficacy and safety of balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension
по: Zheng-Wei Chen, и др.
Опубликовано: (2021-03-01)

Cation exchange chromatography removes FXIa from a 10% intravenous immunoglobulin preparation
по: Gil Bu Kang, и др.
Опубликовано: (2023-11-01)

Inoperable chronic thromboembolic pulmonary hypertension: Evolution of prognosis over 10 years of new emerging therapies
по: Diederik P. Staal, и др.
Опубликовано: (2024-07-01)

Sex-specific cardiopulmonary exercise testing indices to estimate the severity of inoperable chronic thromboembolic pulmonary hypertension
по: Chen TX, и др.
Опубликовано: (2018-01-01)

Improved hemodynamics and cardiopulmonary function in patients with inoperable chronic thromboembolic pulmonary hypertension after balloon pulmonary angioplasty
по: Qi Jin, и др.
Опубликовано: (2019-11-01)

Chronic Thromboembolic Pulmonary Hypertension and ChronicThromboembolic Pulmonary Disease
по: HUANG Shenshen, и др.
Опубликовано: (2023-01-01)

Congruency between clinician‐assessed risk and calculated risk of 1‐year mortality in patients with pulmonary arterial hypertension: A retrospective chart review
по: Amresh Raina, и др.
Опубликовано: (2024-10-01)

Corrigendum: Case report: Selexipag in pediatric pulmonary hypertension: initiation, transition, and titration
по: Jenna M. Faircloth, и др.
Опубликовано: (2023-08-01)

Case Report: Selexipag in pediatric pulmonary hypertension: Initiation, transition, and titration
по: Jenna M. Faircloth, и др.
Опубликовано: (2023-03-01)

Perioperative thromboembolism prophylaxis in children – is it necessary?
по: Izabela Pągowska-Klimek
Опубликовано: (2020-08-01)